3761.bkcmedia.eu
Open in
urlscan Pro
31.7.3.18
Public Scan
URL:
https://3761.bkcmedia.eu/
Submission: On November 08 via api from US — Scanned from NL
Submission: On November 08 via api from US — Scanned from NL
Form analysis 0 forms found in the DOM
Text Content
ESMO 2018 OPTIMIZING EVIDENCE-BASED TREATMENT PLANNING WITH MULTIKINASE INHIBITION IN MCRC AND UHCC SATURDAY, 20 OCTOBER 2018 18.30 – 20.00 HALL A1 – ROOM 16 MESSE MUNICH MUNICH, GERMANY FACULTY Axel Grothey, MD (Chair) Sarah Cannon Cancer Center Nashville, USA Michel Ducreux, MD, PhD Institut Gustave Roussy Villejuif, France Heinz-Josef Lenz, MD University of Southern California Los Angeles, USA Chris Verslype, MD, PhD University Hospital Leuven Leuven, Belgium AGENDA 18.30 – 18.35 Opening Remarks Axel Grothey, MD Axel Grothey, MD View Download Slides 18.35 – 18.50 Mechanistic Insights Into Therapeutic Multikinase Inhibition Heinz-Josef Lenz, MD Heinz-Josef Lenz, MD View Download Slides 18.50 – 19.10 Evidence-Based Treatment Planning With Multikinase Inhibitors in 3L mCRC Axel Grothey, MD Axel Grothey, MD View Download Slides 19.10 – 19.30 Real-World Evidence Value in Treatment Planning in 3L mCRC Michel Ducreux, MD, PhD Michel Ducreux, MD, PhD View Download Slides 19.30 – 19.50 Sequencing in HCC: Establishing a Reliable Standard of Care to Improve Survival Chris Verslype, MD, PhD Chris Verslype, MD, PhD View Download Slides 19.50 – 20.00 Moderated Discussion and Meeting Close Axel Grothey, MD Axel Grothey, MD View Download Slides G.MKT.SM.ON.08.2018.2588